323 related articles for article (PubMed ID: 30248140)
1. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
[TBL] [Abstract][Full Text] [Related]
2. α
Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
[TBL] [Abstract][Full Text] [Related]
3. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α
Gao X; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
Sci Rep; 2018 Feb; 8(1):2730. PubMed ID: 29426850
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
[TBL] [Abstract][Full Text] [Related]
5. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
[TBL] [Abstract][Full Text] [Related]
6. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists.
Eby JM; Abdelkarim H; Albee LJ; Tripathi A; Gao X; Volkman BF; Gaponenko V; Majetschak M
Mol Cell Biochem; 2017 Oct; 434(1-2):143-151. PubMed ID: 28455789
[TBL] [Abstract][Full Text] [Related]
7. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
[TBL] [Abstract][Full Text] [Related]
8. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α
Gao X; Enten GA; DeSantis AJ; Volkman BF; Gaponenko V; Majetschak M
Biochem Biophys Res Commun; 2020 Jul; 528(2):368-375. PubMed ID: 32085899
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle.
Albee LJ; LaPorte HM; Gao X; Eby JM; Cheng YH; Nevins AM; Volkman BF; Gaponenko V; Majetschak M
Open Biol; 2018 Jan; 8(1):. PubMed ID: 29386406
[TBL] [Abstract][Full Text] [Related]
10. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
Evans AE; Tripathi A; LaPorte HM; Brueggemann LI; Singh AK; Albee LJ; Byron KL; Tarasova NI; Volkman BF; Cho TY; Gaponenko V; Majetschak M
Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331810
[TBL] [Abstract][Full Text] [Related]
11. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
Schafer CT; Chen Q; Tesmer JJG; Handel TM
Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
[TBL] [Abstract][Full Text] [Related]
12. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
[TBL] [Abstract][Full Text] [Related]
13. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.
Tripathi A; Vana PG; Chavan TS; Brueggemann LI; Byron KL; Tarasova NI; Volkman BF; Gaponenko V; Majetschak M
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1659-68. PubMed ID: 25775528
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines.
Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM
J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880
[TBL] [Abstract][Full Text] [Related]
15. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Pharmacodynamic Uroselectivity of
Quaresma BMCS; Pimenta AR; Santos da Silva AC; Pupo AS; Romeiro LAS; Silva CLM; Noël F
J Pharmacol Exp Ther; 2019 Oct; 371(1):106-112. PubMed ID: 31285236
[TBL] [Abstract][Full Text] [Related]
17. Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
Zarca A; Perez C; van den Bor J; Bebelman JP; Heuninck J; de Jonker RJF; Durroux T; Vischer HF; Siderius M; Smit MJ
Cells; 2021 Mar; 10(3):. PubMed ID: 33799570
[No Abstract] [Full Text] [Related]
18. Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin.
Seo KK; Lee MY; Lim SW; Kim SC
J Korean Med Sci; 1999 Feb; 14(1):69-74. PubMed ID: 10102527
[TBL] [Abstract][Full Text] [Related]
19. The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.
Gravel S; Malouf C; Boulais PE; Berchiche YA; Oishi S; Fujii N; Leduc R; Sinnett D; Heveker N
J Biol Chem; 2010 Dec; 285(49):37939-43. PubMed ID: 20956518
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
Gustavsson M; Dyer DP; Zhao C; Handel TM
Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
